Search by Drug Name or NDC

    NDC 65862-0959-99 Divalproex Sodium 125 mg/1 Details

    Divalproex Sodium 125 mg/1

    Divalproex Sodium is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is DIVALPROEX SODIUM.

    Product Information

    NDC 65862-0959
    Product ID 65862-959_8e9bfd31-9e95-4357-8fe9-44e441c2a53d
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Divalproex Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Divalproex Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 125
    Active Ingredient Units mg/1
    Substance Name DIVALPROEX SODIUM
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090554
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0959-99 (65862095999)

    NDC Package Code 65862-959-99
    Billing NDC 65862095999
    Package 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (65862-959-99)
    Marketing Start Date 2014-10-24
    NDC Exclude Flag N
    Pricing Information N/A